This webinar will provide an overview of current FDA regulation of pharmacy compounding in the wake of the 2012 meningitis outbreak. It will discuss the legislative efforts taken by Congress to clarify the FDA's authority over compounding pharmacies. The webinar will cover the FDA's traditional approach to regulating compounding, its current policy statement, recent enforcement trends, and two pieces of pending legislation - HR 3089 and HR 3204. Pharmacists, pharmacy technicians, and those in regulatory affairs and quality control in the pharmaceutical industry would benefit from attending.